Academic and Community Cancer Research United

A cancer research network conducting clinical trials that translate the latest

discoveries into new therapies for cancer treatment and symptom management

Disease Group Leaders

ACCRU Disease Group Leaders guide clinical trial research for a designated disease area by:

 

  • Developing the scientific focus and agenda for clinical trial development
  • Evaluating and approving all clinical trial concepts prior to submission for final approval to the Scientific and Administrative Research Committee
  • Implementing, evaluating and reporting of clinical trials within the disease area

 

Leaders by Disease Area

Breast Cancer
Matthew Goetz, M.D., Mayo Clinic Rochester, MN campus

Daniel Flora, M.D., St. Elizabeth Medical Center South

 

Gastrointestinal Cancer
Tanios Bekaii- Saab, M.D., Mayo Clinic, Arizona campus

John Strickler, M.D., Duke University Medical Center

Federico Sanchez, M.D., Aurora Cancer Care - Wilwaukee West

 

Genitourinary Cancer
Lance Pagiliaro, M.D., Mayo Clinic, Rochester, MN campus
Tanya Dorff, M.D., University of Southern California/Norris Comprehensive Cancer Center

 

Lung Cancer
Julian Molina, M.D., Mayo Clinic Rochester, MN campus

 

Lymphoma
Grzegorz Nowakowski, M.D., Mayo Clinic Rochester, MN campus

Tatyana Feldman, M.D., Hackensack University Medical Center

 

Melanoma
Svetomir Markovic, M.D., Ph.D., Mayo Clinic Rochester, MN campus

 

Myeloma
Michael Thompson, M.D., Aurora Cancer Care - Milwaukee West
Shaji Kumar, M.D., Mayo Clinic, Rochester, MN campus

 

Neuro-oncology
Patrick Wen, M.D., Dana-Farber Cancer Institute

 

Sarcoma
 

 

Symptom control
Charles Loprinzi, M.D., Mayo Clinic, Rochester, MN campus